Quality of life impairment in hidradenitis suppurativa: A study of 61 cases

Wolkenstein, Pierre; Loundou, Anderson; Barrau, K.; Auquier, Pascal; Revuz, J.

doi:10.1016/j.jaad.2006.08.061

Cited by 338 publications

(305 citation statements)

References 10 publications

(13 reference statements)

Supporting

Mentioning

273

Contrasting

Unclassified

Order By: Relevance

“…HS is a chronic inflammatory debilitating skin disease and is one of the most distressing conditions observed in dermatology [14][15][16]. Nevertheless, patients experience a significant delay in diagnosis.…”

Section: Discussionmentioning

confidence: 99%

Hidradenitis Suppurativa in General Practice: A Pilot Study

Benhadou¹

2015

J Gen Pract

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Hidradenitis Suppurativa in General Practice: A Pilot Study

Benhadou¹

2015

J Gen Pract

View full text Add to dashboard Cite

show abstract

“…HS can lead to significant morbidity and has been shown to negatively affect quality of life more than skin conditions such as psoriasis and atopic dermatitis [6,7]. It is frequently a chronic disease, with 90% of patients having the disease for an average of 19 years [8].…”

Section: Reviewmentioning

confidence: 99%

Laser and light-based treatments of hidradenitis suppurativa

Yang¹,

2012

Expert Review of Dermatology

View full text Add to dashboard Cite

“…Adverse e®ects on the quality of life for patients with these diseases were more severe than acne vulgaris, atopic dermatitis, psoriasis and other chronic diseases. 5 Although many treatment methods including retinoic acid, glucocorticoid, antibiotics, hormones, tumor necrosis factor antagonist, dapsone and operation have been explored, the therapeutic e®ects are unsatisfactory. No matter what kind of method, frequent relapse and longterm treatment often make patients lose con¯dence for treatment.…”

Section: Introductionmentioning

confidence: 99%

Topical 5-aminolevulinic acid photodynamic therapy improved refractory acne conglobata and perifolliculitis capitis abscedens et suffodiens rather than hidradenitis suppurativa

Zhang

Wang

Shi

et al. 2016

J. Innov. Opt. Health Sci.

View full text Add to dashboard Cite

Acne conglobata (AC), perifolliculitis capitis abscedens et su®odiens (PCAS) and hidradenitis suppurativa (HS) are uncommon refractory chronic, in°ammatory, scarring diseases but cause serious damage to the quality of life. These three diseases are associated with follicular occlusion. Several studies indicated topical 5-aminolevulinic acid photodynamic therapy (ALA-PDT) improved follicular occlusion besides acne treatment. So we attempted to apply ALA-PDT to medicine resistant AC, PCAS and HS. Topical ALA-PDT was applied to 10 patients with AC, seven patients with PCAS and three patients with HS for more than three sessions. All the patients completed the dermatology life quality index (DLQI) questionnaire and were assessed for the e±cacy at the baseline and on two weeks after each treatment. Adverse e®ects were recorded at each visit. The results showed 25.5% (5/20, two cases of AC and three cases of PCAS) of patients achieved excellent improvement after three sessions of PDT and another 60. HS) got poor response (< 20% lesions clearance). Another¯ve cases (three cases of AC and two cases of PCAS) also achieved excellent response after 5-7 sessions of PDT. We also found that papular/nodular, cyst/abscess showed higher clearance rate than sinus/¯stula (88.5%, 86.1% versus 11.1%). DLQI was reduced after three sessions of PDT in AC and PCAS patients rather than HS patients. 5-ALA-PDT could improve refractory AC and PCAS but could not lead to improvement in late stage of HS. The e±cacy increased with more treatment sessions.

show abstract

Quality of life impairment in hidradenitis suppurativa: A study of 61 cases

Cited by 338 publications

References 10 publications

Hidradenitis Suppurativa in General Practice: A Pilot Study

Hidradenitis Suppurativa in General Practice: A Pilot Study

Laser and light-based treatments of hidradenitis suppurativa

Topical 5-aminolevulinic acid photodynamic therapy improved refractory acne conglobata and perifolliculitis capitis abscedens et suffodiens rather than hidradenitis suppurativa

Contact Info

Product

Resources

About